ArticleBMJ open2021
Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19.
Mohammad Bosaeed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it